¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ÇÑÀÇ¿ø °ÆÁ¤³¡

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø, #¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø, #Áú¿°¾ÇÃë, #¼ÛµµÁú¿°¾ÇÃë, #»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø, #Áú¿°¾ÇÃëÇÑÀÇ¿ø, #¼ÛµµÁú¿°¾ÇÃë, #¿¬¼öµ¿»ý¸®ÅëÇÑÀÇ¿ø ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø,,¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø,,Áú¿°¾ÇÃë,,¼ÛµµÁú¿°¾ÇÃë,,»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø,,Áú¿°¾ÇÃëÇÑÀÇ¿ø,,¼ÛµµÁú¿°¾ÇÃë,,¿¬¼öµ¿»ý¸®ÅëÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ¿¬¼öµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ¿¬¼öµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÁú¿°¾ÇÃë, ¸¸¼ºÁú¿°, Æ®¸®Äڸ𳪽ºÁú¿°, ³­ÀÓ, °è·ùÀ¯»ê, Áú°ÇÁ¶Áõ, °í¿î¸¾Ä«µå»ç¿ëÇÑÀÇ¿ø, »ý¸®ºÒ¼ø»ý¸®Åë, À¯»êÈĺ¸¾à, ¿°Áõ¼ºÁú¿°, Æó°æ±âÁõ»ó, ½ÃÇè°üÂø»ó, ÀӽżҾçÁõ, ºÒÀÓÇÑÀÇ¿ø, »ý¸®ÅëÄ¡·á, »ý¸®ÀüÁõ»ó, ÀÓ½ÅÇѾà, ºÒÀÓÁõ, pms, »ý¸®ÅëÄ¡·á, »ý¸®ÁßµÎÅë, ºÒÀÓÇѹæÄ¡·á, ¼ÒÆļö¼úÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»êÈÄ»ý¸®, ºÒ±ÔÄ¢ÇÑ»ý¸®µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ÀÌ°­·¹ÀÌÀú, ¿äÃß°ßÀÎÄ¡·á, µÎ°³°æÃßÃß³ª, ºñ¸¸Ã³¹æ, ¹úµ¶, °ñµµ¹ý°Ë»ç, ÃÊÀ½ÆĽɺο­Ä¡·á, ±³Á¤Ãß³ª, ÀüÀÚ¿ä¹ý, ±â´ÉÀûÀü±âÀÚ±ØÄ¡·á, ÀåħÀü±âÀڱؼú, ±Ý¿¬Ä§, NMES, Àιٵð°Ë»ç, ³ì¿ë, ¹Ì¿ëħ¼ú, ¸¶»çÁö, traction, ¹°¸®Ä¡·á, manipulation, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀ̸ç Àü³² ´ã¾ç±º ´ëÀü¸é, °æ³² ¾ç»ê½Ã ÇϺϸé, °æ³² â¿ø½Ã ÀÇⱸ ¼Ò°èµ¿, ºÎ»ê Áß±¸ â¼±µ¿1°¡, ÀÎõ Áß±¸ Çؾȵ¿1°¡, °æ±â ¾È¼º½Ã ´ç¿Õµ¿, Ãæ³² ¼­»ê½Ã ¿¹Ãµµ¿, °æ±â ±ºÆ÷½Ã ±ÝÁ¤µ¿, ÃæºÏ ¿Áõ±º ¾È³»¸é, ºÎ»ê µ¿±¸ ¼öÁ¤2µ¿, °­¿ø °­¸ª½Ã Ãʴ絿, °æ³² â¿ø½Ã ÁøÇر¸ Ź鵿, °æ³² ÇԾȱº »êÀθé, Àü³² È­¼ø±º È­¼øÀ¾, °­¿ø ¼ÓÃʽà ûȣµ¿, ¼¼Á¾ Àüµ¿¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãᵿ, ¿ï»ê ºÏ±¸ âÆòµ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æºÏ ¾Èµ¿½Ã ºÏÈĸé, ºÎ»ê ¿µµµ±¸ ûÇÐ1µ¿, ÀÎõ ³²µ¿±¸ ³²Ã̵¿, ÀÎõ Áß±¸ Ç×µ¿3°¡, ÀüºÏ ¼øⱺ Àΰè¸é, ºÎ»ê Áß±¸ Áß¾Óµ¿7°¡, ÀüºÏ ÀӽDZº ÀÓ½ÇÀ¾, °æºÏ ¿µÁֽà °¡Èﵿ, °æ³² â¿ø½Ã ÁøÇر¸ Ã湫µ¿, ÀüºÏ ¼øⱺ À¯µî¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãá3µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â ¸¶µµ¸é, ÀÛÀüµ¿, Áßµ¿, ÇÐÀ͵¿, »óµ¿, µµÈ­µ¿, ¼±Çе¿, ³²¾çÀ¾, ¼Û¸²µ¿, ûÇе¿, ¿ëÇöµ¿, °Ë¾Ï, ¹®Çе¿, ³²±¸, Á¤¿Õµ¿, ½ÃÈ­, ºñºÀ¸é, ÀÎõ, ½ÃÈï, ¼­Ã¢µ¿, °è»êµ¿, ¿¬¼öµ¿, µ¿ÀÎõ, ¿¬¼ö±¸, ¼Ûµµ½Åµµ½Ã, ¿î¼­µ¿, ÀÎõ³íÇö, ¼®³²µ¿, µµ¸²µ¿, ¼Û»ê¸é, ¸¸¼öµ¿, °£¼®µ¿, ¸Å¼Û¸é, °è¾ç±¸, µ¿±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017; 215:220. 2. Glanc P, Benacerraf B, Bourne T, et al. First International Consensus Report on Adnexal Masses: Management Recommendations. J Ultrasound Med 2017; 36:849. 3. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85:139. 4. Facchinetti F, Sgarbi L, Piccinini F, Volpe A. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial. Gynecol Endocrinol 2002; 16:39. 5. Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 2004; 82 Suppl 1:S228. 6. Pasquali R, Gambineri A, Cavazza C, et al. Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. Eur J Endocrinol 2011; 164:53. 7. Minaglia S, Mishell DR Jr, Ballard CA. Incisional endometriomas after Cesarean section: a case series. J Reprod Med 2007; 52:630. 8. Mascarenhas MN, Flaxman SR, Boerma T, et al. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 2012; 9:e1001356. 9. Vercellini P, Somigliana E, Consonni D, et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod 2012; 27:3450.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ÇÑÀÇ¿ø °ÆÁ¤³¡""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÇÑÆ÷Áø ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
´ÙÀ½±Û ÀÎõ±¸¾È¿Í»ç ÇÑÀÇ¿ø ȸº¹À§ÇØ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
812 ¾ÆÀÌÁ¶¾Æ 2¿ù ¼³ À̺¥Æ® ¾È³» 0 1,338 2021-02-01
811 ÀÌÈñ¼ºÇÑÀÇ¿ø ¼³³¯ ¼±¹°¼¼Æ® °æ¿Á°í, °øÁø´Ü ÇÒÀÎ À̺¥Æ® 0 4,691 2021-02-01
810 [¹Ý¿ù´çÇÑÀÇ¿ø] "¾Æ¸§´Ù¿òÀÇ ¹ýÄ¢" ¶óÀ²ÇÑÀÇ¿ø 2¿ù EVENT 0 1,292 2021-02-01
809 õ¾ÈÁ¡ ¼û½¬´ÂÇÑÀÇ¿ø 2¿ù Áø·áÀÏÁ¤&¼³³¯À̺¥Æ®¾È³»µå¸³´Ï´Ù 0 973 2021-02-01
808 Ç㵿¼®ÇÑÀÇ¿ø ¼³ ¼±¹°¿ë Ưº°ÇÒÀÎ À̺¥Æ® 0 1,048 2021-01-18
807 °í¿î¼±ÇüÇÑÀÇ¿ø ¼³¸ÂÀÌ ¹î»ìȯ Ãß°¡ÁõÁ¤ À̺¥Æ® 0 1,246 2021-01-18
806 â¿ø ÀÇⱸ µµ°èµ¿ ¿­¸°ÇÑÀÇ¿ø ¼³³¯ À̺¥Æ® 0 1,977 2021-01-18
805 [»ý±âÇÑÀÇ¿ø 1¿ù EVENT!] 2021³â ¿Ô¼Ò! ¶È¶È~¾îµðÀÖ¼Ò EVENT 0 941 2021-01-15
804 ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡ 1¿ù ´ÙÀ̾îÆ® À̺¥Æ® ÇýÅþȳ» 0 1,181 2021-01-15
803 ´ëÀüÇѹ溴¿ø ²Éºû 1¿ù ÇÒÀÎÀ̺¥Æ® 0 2,609 2021-01-11
802 ¼º´©°¡º´¿ø ½Å³â¸ÂÀÌ 1¿ù Çѹæ°ú À̺¥Æ® 0 1,472 2021-01-11
801 Âù´©¸®Çѹ溴¿ø ºäƼŬ¸®´Ð 1¿ù~2¿ù À̺¥Æ® ½ÃÇàÇÕ´Ï´Ù 0 2,036 2021-01-11
800 ±èÇØÁ¦ÁßÇÑÀÇ¿ø 2021 ¼³¸ÂÀÌ °øÁø´Ü, °æ¿Á°í, Á¦Áßȯ À̺¥Æ® 0 1,983 2021-01-11
799 ÇÏ´ÃüÇÑÀÇ¿ø ¾È»ê¿©µå¸§ÈäÅÍ À̺¥Æ® 0 1,921 2021-01-07
798 ÀºÇ೪¹«ÇÑÀÇ¿ø 2021³â »õÇØ À̺¥Æ® 0 1,135 2021-01-07
797 û´ãBSÇÑÀÇ¿ø 2021³â 1¿ù~3¿ù ÇÁ·Î±×·¥ À̺¥Æ®¾È³» 0 1,359 2021-01-07
796 À±½½ÇÑÀÇ¿ø 1ÁÖ³â À̺¥Æ® 0 1,371 2021-01-07
795 ¼ö·ÁÇÑÀÇ¿ø 2021 »õÇؼҸÁ À̺¥Æ® 1 1,299 2021-01-04
794 °­³²´ÙÀ̾îÆ® Àü¹® ¼±ÀÌ°íÀº ÇÑÀÇ¿ø ¼öÇè»ý À̺¥Æ® 0 1,295 2021-01-04
793 Ç⸲´çÇÑÀÇ¿ø 1¿ù ÇÁ·Î¸ð¼Ç ¾È³» 0 1,639 2021-01-04
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷